Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy

被引：0
|
作者：
E. V. Dementyeva
S. P. Medvedev
V. R. Kovalenko
Yu. V. Vyatkin
E. I. Kretov
M. M. Slotvitsky
D. N. Shtokalo
E. A. Pokushalov
S. M. Zakian
机构：
[1] Siberian Branch of the Russian Academy of Sciences,Federal Research Center Institute of Cytology and Genetics
[2] Ministry of Health of Russian Federation,Meshalkin National Medical Research Center
[3] Siberian Branch of the Russian Academy of Sciences,Institute of Chemical Biology and Fundamental Medicine
[4] Novosibirsk State University,undefined
[5] Novel Software Systems Ltd,undefined
[6] Moscow Institute of Physics and Technology,undefined
[7] A. P. Ershov Institute of Informatics Systems,undefined
来源：
Biochemistry (Moscow) | 2019年 / 84卷
关键词：
induced pluripotent stem cells; human disease models; hypertrophic cardiomyopathy; cardiomyocytes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Generation of patient-specific induced pluripotent stem cells (iPSCs) and their subsequent differentiation into cardiomyocytes opened new opportunities for studying pathogenesis of inherited cardiovascular diseases. One of these diseases is hypertrophic cardiomyopathy (HCM) for which no efficient therapy methods have been developed so far. In this study, the approach based on patient-specific iPSCs was applied to create a model of the disease. Genetic analysis of a hypertrophic cardiomyopathy patient revealed R326Q mutation in the MYBPC3 gene. iPSCs of the patient were generated and characterized. The cells were differentiated into cardiomyocytes together with the control iPSCs from a healthy donor. The patient’s iPSC-derived cardiomyocytes exhibited early HCM features, such as abnormal calcium handling and increased intracellular calcium concentration. Therefore, cardiomyocytes obtained by directed differentiation of iPSCs from the HCM patient can be used as a model system to study HCM pathogenesis.
引用
收藏
页码：291 / 298
页数：7
相关论文
共 50 条
  • [1] Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy
    Dementyeva, E. V.
    Medvedev, S. P.
    Kovalenko, V. R.
    Vyatkin, Yu. V.
    Kretov, E. I.
    Slotvitsky, M. M.
    Shtokalo, D. N.
    Pokushalov, E. A.
    Zakian, S. M.
    BIOCHEMISTRY-MOSCOW, 2019, 84 (03) : 291 - 298
  • [2] Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
    Han, Lu
    Li, Yang
    Tchao, Jason
    Kaplan, Aaron D.
    Lin, Bo
    Li, You
    Mich-Basso, Jocelyn
    Lis, Agnieszka
    Hassan, Narmeen
    London, Barry
    Bett, Glenna C. L.
    Tobita, Kimimasa
    Rasmusson, Randall L.
    Yang, Lei
    CARDIOVASCULAR RESEARCH, 2014, 104 (02) : 258 - 269
  • [3] Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy
    Sun, Ning
    Yazawa, Masayuki
    Liu, Jianwei
    Han, Leng
    Sanchez-Freire, Veronica
    Abilez, Oscar J.
    Navarrete, Enrique G.
    Hu, Shijun
    Wang, Li
    Lee, Andrew
    Pavlovic, Aleksandra
    Lin, Shin
    Chen, Rui
    Hajjar, Roger J.
    Snyder, Michael P.
    Dolmetsch, Ricardo E.
    Butte, Manish J.
    Ashley, Euan A.
    Longaker, Michael T.
    Robbins, Robert C.
    Wu, Joseph C.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (130)
  • [4] Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
    Lan, Feng
    Lee, Andrew
    Liang, Ping
    Navarrete, Enrique
    Wang, Li
    Leng, Han
    Sanchez, Veronica
    Yen, Michelle
    Wang, Yongming
    Nguyen, Patricia
    Sun, Ning
    Abilez, Oscar
    Lewis, Richard
    Yamaguchi, Yoshinori
    Ashley, Euan
    Bers, Donald
    Robbins, Robert
    Longaker, Michael
    Wu, Joseph
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [5] Patient-Specific Induced Pluripotent Stem Cell as a Model for Familial Dilated Cardiomyopathy
    Sun, Ning
    Yazawa, Masayuki
    Liu, Jianwei
    Han, Leng
    Sanchez-Freire, Veronica
    Hu, Shijun
    Ricardo, Dolmetsch
    Butte, Manish
    Ashley, Euan
    Longaker, Michael
    Robbins, Robert
    Wu, Joseph
    CIRCULATION, 2011, 124 (21)
  • [6] Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells
    Lan, Feng
    Lee, Andrew S.
    Liang, Ping
    Sanchez-Freire, Veronica
    Nguyen, Patricia K.
    Wang, Li
    Han, Leng
    Yen, Michelle
    Wang, Yongming
    Sun, Ning
    Abilez, Oscar J.
    Hu, Shijun
    Ebert, Antje D.
    Navarrete, Enrique G.
    Simmons, Chelsey S.
    Wheeler, Matthew
    Pruitt, Beth
    Lewis, Richard
    Yamaguchi, Yoshinori
    Ashley, Euan A.
    Bers, Donald M.
    Robbins, Robert C.
    Longaker, Michael T.
    Wu, Joseph C.
    CELL STEM CELL, 2013, 12 (01) : 101 - 113
  • [7] Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
    Tokuyama, Takeshi
    Ahmed, Razan Elfadil
    Chanthra, Nawin
    Anzai, Tatsuya
    Uosaki, Hideki
    BIOLOGY-BASEL, 2021, 10 (10):
  • [8] Patient-specific induced pluripotent stem cells (iPSCs) to model metachromatic leukodystrophy
    Frati, G.
    Luciani, M.
    Meneghini, V.
    Cavazzin, C.
    De Cicco, S.
    Lombardo, A.
    Paulis, M.
    Morena, F.
    Sanvito, F.
    Villa, A.
    Stahlman, M.
    Blomqvist, M.
    Martino, S.
    Gritti, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A81 - A81
  • [9] Modeling LMNA Associated Cardiomyopathy Using Patient-Specific Human Induced Pluripotent Stem Cells
    Fonoudi, Hananeh
    Wilcox, Jane
    Burridge, Paul W.
    CIRCULATION RESEARCH, 2020, 127
  • [10] Patient-Specific Induced Pluripotent Stem Cells in Hurler Syndrome
    Tolar, Jakub
    Park, In-Hyun
    Xia, Lily
    Osborn, Mark
    McElmurry, Ron T.
    Orchard, Paul J.
    Daley, George Q.
    Blazar, Bruce R.
    BLOOD, 2008, 112 (11) : 149 - 149
12345